INDV 250117 2.50C (INDV250117C2500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

INDV250117C2500

Watchlist

0.00
0.000.00%

15min DelayClose Dec 27 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Indivior Announces Share Repurchase and Cancellation
TipRanksDec 24 02:07 ET
Indivior Director Acquires Significant Shareholding
TipRanksDec 23 05:37 ET
Jefferies Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $24.41
Moomoo NewsDec 17 12:31 ET · Ratings
Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating
Moomoo NewsDec 17 09:31 ET · Ratings
Craig-Hallum Reaffirms Their Buy Rating on Indivior (INDV)
TipRanksDec 17 08:55 ET · Ratings
Indivior CFO to Step Down From Board Following Discussions With Oaktree Capital
MT NewswiresDec 17 03:15 ET

Comments

Jaguar8

Oct 10 06:07

NEWS

$Indivior (INDV.US)$
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...

Moomoo AI

Feb 22 08:25

Indivior's potential U.S. market move reflects its growth opportunities and is expected to attract more U.S. investors. Strong financial performance and positive revenue outlook may also boost investor interest.

Indivior Shares Jump on Possible U.S. Listing, Swing to Pretax Profit